Bernstein Harold (CIK 2050172) reported 43 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-08). Recent activity: Sell MAZE (9,705 shares), Sell MAZE (4,481 shares), Sell MAZE (625 shares), Sell MAZE (5,130 shares), Sell MAZE (59 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-08 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 9,705 | $254,502 |
| 2026-09-04 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 4,481 | $118,191 |
| 2026-09-04 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 625 | $16,951 |
| 2026-09-04 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 5,130 | $133,448 |
| 2026-09-04 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 59 | $1,521 |
| 2026-09-03 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Buy | 16,141 | $168,189 |
| 2026-09-03 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 16,141 | $425,512 |
| 2026-09-03 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Buy | 20,000 | $0 |
| 2026-08-14 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Buy | 16,142 | $168,200 |
| 2026-08-14 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 16,142 | $445,621 |
| 2026-07-02 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 1,200 | $36,404 |
| 2026-07-02 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 13,409 | $400,460 |
| 2026-07-02 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Buy | 14,609 | $152,226 |
| 2026-06-03 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Buy | 14,853 | $154,768 |
| 2026-06-03 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 13,253 | $338,879 |
| 2026-06-03 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 1,600 | $42,176 |
| 2026-05-18 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Buy | 15,000 | $156,300 |
| 2026-05-18 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 15,000 | $393,300 |
| 2026-04-02 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Buy | 15,000 | $156,300 |
| 2026-04-02 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 11,352 | $331,932 |
| 2026-04-02 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 3,348 | $100,641 |
| 2026-04-02 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 300 | $9,321 |
| 2026-03-20 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Buy | 15,000 | $156,300 |
| 2026-03-20 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 6,161 | $296,960 |
| 2026-03-20 | Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Sell | 3,795 | $187,169 |
来源：SEC Form 4 申报文件 · 截至 2026-09-08